Common Contracts
3 similar Softgel Commercial Manufacturing and Packaging Agreement contracts by Insys Therapeutics, Inc.
EX-10.12 9 dex1012.htm SOFTGEL COMMERCIAL MANUFACTURING AND PACKAGING AGREEMENT ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406....Softgel Commercial Manufacturing and Packaging Agreement • May 5th, 2020 • New Jersey
This Softgel Commercial Manufacturing and Packaging Agreement (“Agreement”) is made this 21st day of March, 2011, by and between Catalent Pharma Solutions, LLC, a Delaware limited liability company, having a place of business at 14 Schoolhouse Road, Somerset, New Jersey 08873 (“Catalent”) and Insys Therapeutics, Inc., a Delaware corporation, having its principal place of business at 10220 S. 51st Street, Suite 2, Phoenix, AZ 85044 (“Client”).
SOFTGEL COMMERCIAL MANUFACTURING AND PACKAGING AGREEMENTSoftgel Commercial Manufacturing and Packaging Agreement • July 15th, 2011 • Insys Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This Softgel Commercial Manufacturing and Packaging Agreement (“Agreement”) is made this 21st day of March, 2011, by and between Catalent Pharma Solutions, LLC, a Delaware limited liability company, having a place of business at 14 Schoolhouse Road, Somerset, New Jersey 08873 (“Catalent”) and Insys Therapeutics, Inc., a Delaware corporation, having its principal place of business at 10220 S. 51st Street, Suite 2, Phoenix, AZ 85044 (“Client”).
SOFTGEL COMMERCIAL MANUFACTURING AND PACKAGING AGREEMENTSoftgel Commercial Manufacturing and Packaging Agreement • June 28th, 2011 • Insys Therapeutics, Inc. • Pharmaceutical preparations • New Jersey
This Softgel Commercial Manufacturing and Packaging Agreement (“Agreement”) is made this 21st day of March, 2011, by and between Catalent Pharma Solutions, LLC, a Delaware limited liability company, having a place of business at 14 Schoolhouse Road, Somerset, New Jersey 08873 (“Catalent”) and Insys Therapeutics, Inc., a Delaware corporation, having its principal place of business at 10220 S. 51st Street, Suite 2, Phoenix, AZ 85044 (“Client”).
